Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
Quick Stats
Jun 03, 202657.5
AI Score
HOLD1.03
Volume Ratio
May 28, 2026
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
REPL Stock Summary
Last updated Jun 03, 2026
REPL is currently trading at $9.98, positioned above its 200-day moving average of $6.85, indicating a long-term uptrend. The stock has a 52-week range of $1.5 to $13.24.
Technical Analysis: The 50-day moving average stands at $4.86, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 78.69, suggesting the stock is in overbought territory (bullish but caution advised).
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.204, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates REPL at 57.5/100 with a HOLD recommendation.
REPL (Replimune Group, Inc.) Indicators
Last updated Jun 03, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 78.69 |
| CMF (20) | 0.204 |
| ROC (10) | 112.34 |
| ADX (14) | 36.238 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 1.188 |
| AROONOSC (14) | 100.0 |
| WILLAMS %R (14) | -7.317 |
| MFI (14) | 83.956 |
REPL Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
REPL Price vs Max Options Open Interest
REPL Max Change In Options Open Interest
REPL Options - Sort by Max open Interest (near term)
3rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
REPL Daily Out of Money Options - Sort by Max open Interest (near term)
3rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
REPL Daily In the Money Options - Sort by Max open Interest (near term)
3rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
REPL Most Active Options by Volume(near term)
3rd June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Replimune Group, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
REPL Moving Averages Analysis
Replimune Group, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jun 03, 2026
Replimune Group, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jun 03, 2026
REPL (Replimune Group, Inc.) Simple Moving Averages
Moving Averages are last updated Jun 03, 2026
| Days | MA |
|---|---|
| 10 | 6.58 |
| 20 | 5.48 |
| 30 | 4.53 |
| 50 | 4.86 |
| 100 | 6.22 |
| 200 | 6.85 |
REPL Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 743.2 million |
| Earnings/Share ($) | -3.44 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.275 |
| EPS Estimate Next Year ($) | -2.064 |
| WallStreet Target Price ($) | 4.6667 |
| Most Recent Quarter |